{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:59:10Z","timestamp":1774126750912,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"crossref","award":["KTPYJ2021014"],"award-info":[{"award-number":["KTPYJ2021014"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94626-6","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T05:27:06Z","timestamp":1742534826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiological characteristics and treatment challenges of chronic hepatitis C in the kashi region of xinjiang china: A retrospective investigation from 2018 to 2022"],"prefix":"10.1038","volume":"15","author":[{"given":"Mingna","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuerbannisa","family":"Wulayin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shutao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"94626_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","author":"HCVC Polaris Observatory","year":"2017","unstructured":"Polaris Observatory, H. C. V. C. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol. Hepatol. 2, 161\u2013176. https:\/\/doi.org\/10.1016\/S2468-1253(16)30181-9 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"94626_CR2","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","volume":"69","author":"L Pimpin","year":"2018","unstructured":"Pimpin, L. et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J. Hepatol. 69, 718\u2013735. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.011 (2018).","journal-title":"J. Hepatol."},{"key":"94626_CR3","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1111\/liv.15452","volume":"42","author":"G Ouyang","year":"2022","unstructured":"Ouyang, G. et al. Incidence trends of acute viral hepatitis caused by four viral etiologies between 1990 and 2019 at the global, regional and National levels. Liver Int. 42, 2662\u20132673. https:\/\/doi.org\/10.1111\/liv.15452 (2022).","journal-title":"Liver Int."},{"key":"94626_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang, D. Q. et al. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat. Rev. Gastroenterol. Hepatol. 20, 388\u2013398. https:\/\/doi.org\/10.1038\/s41575-023-00759-2 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"94626_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","volume":"7","author":"POH Collaborators","year":"2022","unstructured":"Collaborators, P. O. H. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol. Hepatol. 7, 396\u2013415. https:\/\/doi.org\/10.1016\/S2468-1253(21)00472-6 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"94626_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","volume":"14","author":"AP Thrift","year":"2017","unstructured":"Thrift, A. P., El-Serag, H. B. & Kanwal, F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat. Rev. Gastroenterol. Hepatol. 14, 122\u2013132. https:\/\/doi.org\/10.1038\/nrgastro.2016.176 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"94626_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.16462\/j.cnki.zhjbkz.2023.02.019","volume":"27","author":"A Saimaiti","year":"2023","unstructured":"Saimaiti, A., Xie, C. M., Maimait, H. & Hei, F. X. Epidemiological characteristics of hepatitis C in Kashgar, Xinjiang during 2005\u20132019. Chin. J. Dis. Control Prev. 27, 244\u2013248. https:\/\/doi.org\/10.16462\/j.cnki.zhjbkz.2023.02.019 (2023).","journal-title":"Chin. J. Dis. Control Prev."},{"key":"94626_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332177","author":"E Vo-Quang","year":"2024","unstructured":"Vo-Quang, E. & Pawlotsky, J. M. Unusual\u2019 HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment. Gut https:\/\/doi.org\/10.1136\/gutjnl-2024-332177 (2024).","journal-title":"Gut"},{"key":"94626_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.virol.2018.01.015","volume":"516","author":"K Huang","year":"2018","unstructured":"Huang, K. et al. Molecular evolution of hepatitis C virus in China: A nationwide study. Virology 516, 210\u2013218. https:\/\/doi.org\/10.1016\/j.virol.2018.01.015 (2018).","journal-title":"Virology"},{"key":"94626_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3760\/cma.j.cn501113-20190522-00181","volume":"28","author":"M Anaerguli","year":"2020","unstructured":"Anaerguli, M. et al. Distribution characteristics of hepatitis C virus genotypes in Xinjiang. Chin. J. Hepatol. 28, 494\u2013498. https:\/\/doi.org\/10.3760\/cma.j.cn501113-20190522-00181 (2020).","journal-title":"Chin. J. Hepatol."},{"key":"94626_CR11","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis. 53","author":"WHO","year":"2016","unstructured":"WHO. Global Health Sector Strategy on Viral Hepatitis 2016\u20132021. Towards Ending Viral Hepatitis. 53 (World Health Organization, 2016)."},{"key":"94626_CR12","doi-asserted-by":"publisher","unstructured":"Chen, Y. et al. A sero-epidemiological study on hepatitis C in China. Chin. J. Epidemiol. 888\u2013891. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2011.09.009 (2011).","DOI":"10.3760\/cma.j.issn.0254-6450.2011.09.009"},{"key":"94626_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.14218\/JCTH.2018.00027","volume":"6","author":"ZW Chen","year":"2018","unstructured":"Chen, Z. W. et al. Large disparity between prevalence and treatment rates for hepatitis C in Western China. J. Clin. Transl Hepatol. 6, 385\u2013390. https:\/\/doi.org\/10.14218\/JCTH.2018.00027 (2018).","journal-title":"J. Clin. Transl Hepatol."},{"key":"94626_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3855\/jidc.18331","volume":"18","author":"Q Du","year":"2024","unstructured":"Du, Q. et al. Distribution and genotyping of hepatitis C virus (HCV) infection in Gansu Province, China. J. Infect. Dev. Ctries. 18, 458\u2013463. https:\/\/doi.org\/10.3855\/jidc.18331 (2024).","journal-title":"J. Infect. Dev. Ctries."},{"key":"94626_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S2468-1253(19)30085-8","volume":"4","author":"A Trickey","year":"2019","unstructured":"Trickey, A. et al. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. Lancet Gastroenterol. Hepatol. 4, 435\u2013444. https:\/\/doi.org\/10.1016\/S2468-1253(19)30085-8 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"94626_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.drugpo.2019.05.005","volume":"70","author":"Y Bao","year":"2019","unstructured":"Bao, Y. et al. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis. Int. J. Drug Policy. 70, 87\u201393. https:\/\/doi.org\/10.1016\/j.drugpo.2019.05.005 (2019).","journal-title":"Int. J. Drug Policy"},{"key":"94626_CR17","doi-asserted-by":"publisher","unstructured":"Guideline for the prevention and treatment of hepatitis C. Chinese Journal of Hepatology 30, 1332\u20131348, (2022). version https:\/\/doi.org\/10.3760\/cma.j.cn501113-20221220-00605 (2022).","DOI":"10.3760\/cma.j.cn501113-20221220-00605"},{"key":"94626_CR18","unstructured":"Polaris Observatory, H. C. V. C. HCV Infections (2022), (2024). https:\/\/cdafound.org\/polaris-countries-dashboard\/#footnote-hcv"},{"key":"94626_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.46234\/ccdcw2024.001","volume":"6","author":"D Yang","year":"2024","unstructured":"Yang, D. et al. Diagnosis, treatment, and associated factors among patients with HCV Infection - Jiangsu Province, China, 2004\u20132020. China CDC Wkly. 6, 1\u20135. https:\/\/doi.org\/10.46234\/ccdcw2024.001 (2024).","journal-title":"China CDC Wkly."},{"key":"94626_CR20","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Hepatitis C knowledge and Self-Reported testing behavior in the general population in China: online Cross-Sectional survey. JMIR Public. Health Surveill. 9 https:\/\/doi.org\/10.2196\/39472 (2023).","DOI":"10.2196\/39472"},{"key":"94626_CR21","doi-asserted-by":"publisher","unstructured":"Chang, L. J. et al. Factors associated with the refusal of Direct-Acting antiviral agents for the treatment of hepatitis C in Taiwan. Med. (Kaunas). 58. https:\/\/doi.org\/10.3390\/medicina58040521 (2022).","DOI":"10.3390\/medicina58040521"},{"key":"94626_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.aohep.2018.06.001","volume":"18","author":"M Malespin","year":"2019","unstructured":"Malespin, M. et al. Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic. Ann. Hepatol. 18, 304\u2013309. https:\/\/doi.org\/10.1016\/j.aohep.2018.06.001 (2019).","journal-title":"Ann. Hepatol."},{"key":"94626_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/14787210.2020.1758065","volume":"18","author":"G Esmat","year":"2020","unstructured":"Esmat, G., Elbaz, T., Elsharkawy, A., Abdullah, M. & El Kassas, M. Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt. Expert Rev. Anti Infect. Ther. 18, 637\u2013642. https:\/\/doi.org\/10.1080\/14787210.2020.1758065 (2020).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"94626_CR24","doi-asserted-by":"publisher","first-page":"e14050","DOI":"10.1111\/jvh.14050","volume":"32","author":"MA Qureshi","year":"2025","unstructured":"Qureshi, M. A. & Health Systems Strengthening approach to address the high burden of hepatitis C in Pakistan. J. Viral Hepat. 32, e14050. https:\/\/doi.org\/10.1111\/jvh.14050 (2025).","journal-title":"J. Viral Hepat."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94626-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94626-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94626-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T23:48:33Z","timestamp":1742600913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94626-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94626"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94626-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work was conducted according to the Helsinki Declaration as revised in 2013. It was approved by the Institutional Review Board of the First People\u2019s Hospital of Kashi (No. 2022-03). Due to the retrospective nature of the study, an exemption from informed consent was granted by the Institutional Review Board of the First People\u2019s Hospital of Kashi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"9726"}}